A new trading day began on Monday, with Enlivex Therapeutics Ltd (NASDAQ: ENLV) stock price up 13.74% from the previous day of trading, before settling in for the closing price of $0.9. ENLV’s price has ranged from $0.83 to $2.10 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 7.57% over the last five years. Meanwhile, its annual earnings per share averaged 20.58%. With a float of $22.76 million, this company’s outstanding shares have now reached $24.29 million.
Enlivex Therapeutics Ltd (ENLV) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Enlivex Therapeutics Ltd is 4.61%, while institutional ownership is 4.58%.
Enlivex Therapeutics Ltd (ENLV) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.23 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.46% during the next five years compared to 7.57% growth over the previous five years of trading.
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Trading Performance Indicators
Here are Enlivex Therapeutics Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Enlivex Therapeutics Ltd (ENLV)
Analysing the last 5-days average volume posted by the [Enlivex Therapeutics Ltd, ENLV], we can find that recorded value of 41.85 million was better than the volume posted last year of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 17.01%.
During the past 100 days, Enlivex Therapeutics Ltd’s (ENLV) raw stochastic average was set at 14.87%, which indicates a significant decrease from 19.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1012 in the past 14 days, which was higher than the 0.0867 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0486, while its 200-day Moving Average is $1.0846. Now, the first resistance to watch is $1.5533. This is followed by the second major resistance level at $2.0867. The third major resistance level sits at $2.3633. If the price goes on to break the first support level at $0.7433, it is likely to go to the next support level at $0.4667.
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Key Stats
With a market capitalization of 24.34 million, the company has a total of 24,293K Shares Outstanding. Currently, annual sales are 0 K while annual income is -15,010 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,870 K.
